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Abstract 
Null mutants are essential for analyzing gene function. Here, we describe a simple and 
efficient method to generate Caenorhabditis elegans null mutants using CRISPR/Cas9 and 
short single stranded DNA oligo repair templates to insert a universal 43-nucleotide-long knock-
in cassette (STOP-IN) into the early exons of target genes. This STOP-IN cassette has stop 
codons in all three reading frames and leads to frameshifts, which will generate putative null 
mutations regardless of the reading frame of the insertion position in exons. The STOP-IN 
cassette also contains an exogenous Cas9 target site that allows further genome editing and 
provides a unique sequence that simplifies the identification of successful insertion events via 
PCR. As a proof of concept, we inserted the STOP-IN cassette right at a Cas9 target site in 
aex-2 to generate new putative null alleles by injecting preassembled Cas9 ribonucleoprotein 
and a short synthetic single stranded DNA repair template containing the STOP-IN cassette and 
two ~35-nucleotide-long homology arms identical to the sequences flanking the Cas9 cut site. 
We showed that these new aex-2 alleles phenocopied an existing loss-of-function allele of aex-2. 
We further showed that the new aex-2 null alleles could be reverted back to the wild-type 
sequence by targeting the exogenous Cas9 cut site included in the STOP-IN cassette and 
providing a single stranded wild-type DNA repair oligo. We applied our STOP-IN method to 
generate new putative null mutants for 20 additional genes, including three pharyngeal muscle-
specific genes (clik-1, clik-2, and clik-3), and reported a high insertion rate (46%) based on the 
animals we screened. We showed that null mutations of clik-2 cause recessive lethality with a 
severe pumping defect and clik-3 null mutants have a mild pumping defect, while clik-1 is 
dispensable for pumping. We expect that the knock-in method using the STOP-IN cassette will 
facilitate the generation of new null mutants to understand gene function in C. elegans and other 
genetic model organisms.   
  
3 
 
Introduction 
 An essential goal of genetics is to understand gene function. Loss-of-function or null 
mutants, in which gene activity is reduced or completely lost, are valuable reagents that enable 
this goal. Caenorhabditis elegans has become an important model organism since the first 
description of its genetics by Brenner (Brenner 1974), allowing study of conserved mechanisms 
underlying many important biological processes, such as programed cell death, neural 
development, and RNA interference (Corsi et al. 2015). Among other useful features, the 
availability of a large number of loss-of-function and null C. elegans mutants has been important 
for the success of C. elegans research. Many of these mutants have been isolated by screening 
worms treated with mutagens or transposons (Vallin et al. 2012; C. elegans Deletion Mutant 
Consortium 2012; Thompson et al. 2013; Kutscher and Shaham 2014). While these mutants 
allow us to infer the nature of a gene’s normal function and to place genes into genetic networks 
using epistasis analyses, many of them may also contain background mutations that can 
confound the interpretation of the functional importance of the gene of interest. In addition, a 
significant fraction of C. elegans genes have only reduction-of-function alleles or simply no 
mutant alleles at all. As such, an efficient and convenient way to generate null mutants in the 
wild-type background would be of great interest. Here, we report a simple and robust method 
using CRISPR/Cas9 and a universal stop knock-in (STOP-IN) cassette to achieve this purpose. 
The CRISPR/Cas9 system was originally identified in bacterial and archaeal immune 
systems as a defense against viruses (Wiedenheft et al. 2012). Cas9 protein from the bacterium 
Streptococcus pyogenes is an RNA-guided endonuclease that creates site-specific cleavage of 
double stranded DNA. Cas9 protein complexes with two small RNAs to form a functional Cas9 
ribonucleoprotein: a CRISPR RNA (crRNA) that determines the target specificity of Cas9 
nuclease activity, and a trans-activating crRNA (tracrRNA) that acts as a scaffold (Gasiunas et 
al. 2012; Jinek et al. 2012). The Cas9 ribonucleoprotein recognizes the DNA target that is 
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homologous to the first 20 nucleotides of the crRNA guide sequence and is followed by a 
protospacer adjacent motif (PAM), which in the case of S. pyogenes is 5’-NGG-3’, and 
generates a double-strand break three base pairs upstream of the PAM site (Figure 1A). After 
the break is generated, the DNA strands can be re-joined through error-prone non-homologous 
end joining (NHEJ) or precise homology directed repair (HDR). The CRISPR/Cas9 system was 
engineered for modification of genomes in mammalian cells and has since revolutionized the 
field of genome editing (Cong et al. 2013; Mali et al. 2013). 
 The CRISPR/Cas9 system has also been successfully adopted for genome editing in 
C. elegans by injecting plasmids, RNA, and/or protein of the CRISPR/Cas9 system in the 
gonads of adult hermaphrodites (Chen et al. 2013; Cho et al. 2013; Katic and Großhans 2013; 
Lo et al. 2013; Tzur et al. 2013; Waaijers et al. 2013; Friedland et al. 2013; Dickinson et al. 2013; 
Chiu et al. 2013). Different strategies have been described to facilitate identification of desired 
genome editing events (reviewed by Dickinson and Goldstein 2016). For example, co-
conversion and co-CRISPR methods effectively enrich for animals that have the desired 
genome alterations: animals with successful genome editing at the co-conversion locus with a 
dominant visible phenotype, such as dpy-10, are likely to have edits at another independent 
locus (Ward 2014; Kim et al. 2014; Arribere et al. 2014).  
Several CRISPR approaches have been described to generate loss-of-function alleles or 
null alleles for C. elegans genes, in which deletions, insertions, or premature nonsense 
mutations were introduced at specific loci. Without a repair template, error-prone NHEJ 
generally creates deletions or insertions with unpredictable flanking sequences in target genes 
after Cas9 cutting (Katic and Großhans 2013; Friedland et al. 2013; Chiu et al. 2013; Chen et al. 
2014). In addition, some NHEJ-mediated insertions or deletions could be in-frame, which may 
only marginally reduce gene activity. For mutants that have unknown phenotypes, PCR is 
commonly used to detect the desired genome edit. The detection of small deletions and/or 
insertions via PCR is rather laborious, as the PCR products generally need to be denatured, 
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annealed, and treated with enzymes that recognize mismatches, such as CEL-1 nuclease and 
T7 Endonuclease I, to identify candidates with successful editing. When repair templates with 
long homology arms are used, HDR can produce precise insertion of large exogenous 
sequences, such as gfp or an antibiotic selection cassette, to disrupt or replace the gene of 
interest (Chen et al. 2013; Tzur et al. 2013; Norris et al. 2015). Although several vectors have 
been developed to facilitate the preparation of such repair templates (Dickinson et al. 2015; 
Schwartz and Jorgensen 2016), laborious molecular cloning may be required to construct repair 
template plasmids with long homology arms. In addition, large insertions or deletions may affect 
the expression of the neighboring genes (Tzur et al. 2013). Single stranded DNA oligos with 
short homology arms (~30-60 nucleotides) can efficiently serve as repair templates to insert up 
to 130 nucleotides into the C. elegans genome with CRISPR/Cas9 (Paix et al. 2017). In 
previous attempts to make knock-outs by introducing a single stop codon, the reading frame of 
the target gene would need to be considered and additional mutations were also needed to 
prevent re-cutting by Cas9 and/or to introduce a restriction enzyme site for detection of 
successful genome modification (Paix et al. 2017).   
 We sought to develop an easy and efficient CRISPR/Cas9 method to generate putative 
null mutants with pre-defined mutations in C. elegans. To this end, we designed a 43-
nucleotide-long universal stop knock-in (STOP-IN) cassette that will create stop codons and 
frameshifts in all three reading frames. We describe an efficient co-conversion CRISPR method 
in which preassembled Cas9 ribonucleoprotein and short single stranded DNA oligo repair 
templates are used to generate putative null alleles by inserting the STOP-IN cassette into the 
coding regions of target genes. The universal STOP-IN cassette allows the usage of a common 
internal primer for easy detection of putative null alleles with successful insertion via PCR. The 
resultant null alleles can be reverted to the original wild-type sequence via a second oligo-
directed CRISPR/Cas9 editing targeting the exogenous Cas9 target site included in the STOP-
IN cassette.  
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Materials and Methods 
Maintenance of Strains 
All C. elegans strains were maintained on NGM plates seeded with the E. coli strain 
OP50 as food, at room temperature, as described (Brenner 1974). The following strains were 
used: wild type (the N2 Bristol strain), JT3 aex-2(sa3) X, and a balancer strain FX30236 
tmC30[ubc-17(tmIs1243)] X (Dejima et al. 2018). Strains generated in this study are listed in 
Supplemental Table S1. 
Design of guide RNA sequences 
All crRNAs and the universal tracrRNA were chemically synthesized (the Alt-R system 
from IDT, Coralville, IA). Synthetic crRNAs and tracrRNA were dissolved in nuclease-free water 
(IDT) to make 100 µM working stocks. The guide sequences of all crRNAs used in this study are 
provided in Supplemental Table S2. We used a CRISPR guide sequence selection tool 
(http://genome.sfu.ca/crispr/search.html) designed for the C. elegans genome (Au et al. 2018) to 
identify guide sequences within the coding sequences of target genes; one guide sequence was 
selected for each gene of interest. We only selected guide sequences followed by the PAM site 
(5’-NGG-3’) for Streptococcus pyogenes Cas9. The guide sequences in early exons shared by 
all known isoforms of the gene of interest were preferred, as we suspected early stop codons 
and frameshifts introduced by our STOP-IN method in these regions would be more likely to 
produce putative null mutants.  
Design of repair DNA oligos 
All single stranded DNA repair oligos (~113 nucleotides) were synthesized (4nmol, 
Ultramer DNA oligos from IDT, Coralville, IA) and diluted in nuclease-free water (IDT). The 
sequences of DNA repair oligos used in this study are described in Supplementary Table S2. 
Our universal stop knock-in (STOP-IN) cassette (43 nucleotides,  5’- 
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GGGAAGTTTGTCCAGAGCAGAGGTGACTAAGTGATAAGCTAGC-3’) is composed of an 
exogenous Cas9 target site with a PAM site (underlined) that has been shown to work in 
C. elegans (Paix et al. 2017), multiple stop codons in all three reading frames, and the 
recognition site of the restriction enzyme NheI  (Figure 1B).  
To achieve high knock-in efficiency, we implemented two rules for the design of single-
stranded DNA repair oligos. First, the efficiency of homology directed repair (HDR) correlates 
inversely with the distance between homology arms and the Cas9 cut site (Paquet et al. 2016). 
Thus, in addition to the STOP-IN cassette, each single stranded DNA repair oligo also contains 
two unique homology arms (~35 nucleotides for each) that are identical to sequences 
immediately flanking the Cas9 cut site, such that the universal STOP-IN cassette will be directly 
inserted at the cut site. In addition, successful insertion will disrupt the original Cas9 target site 
preventing the knock-in locus from being re-cut by Cas9, and removing the need to introduce 
additional mutations in the repair template. Second, it has also been demonstrated that the 
sense of the single stranded DNA repair oligo relative to the PAM site affects the genome 
editing efficiency: if the modification occurs at 5’ to the PAM site (5’-NGG-3’), the DNA repair 
oligo containing sequence from the same strand as the PAM site has higher knock-in efficiency; 
if the modification occurs at 3’ to the PAM site, the DNA repair oligo containing the reverse 
complement sequence of the strand with the PAM site has higher knock-in efficiency (Behnon 
Farboud and Barbara J. Meyer, personal communication). As the universal STOP-IN cassette 
needs to be inserted at the Cas9 cut site on the coding strand (three nucleotides upstream of 
the PAM site) to generate putative null mutants, the single stranded DNA oligo should be on the 
same strand that carries the PAM site (5’- NGG-3’) for high knock-in efficiency. Thus, the 
direction of the single stranded DNA repair oligo (sense or anti-sense) is dependent on whether 
the PAM site is on the coding strand or the non-coding strand (Figure 1E). A detailed step-by-
step protocol to design DNA repair oligos is included in Supplemental File S1. 
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Microinjection of Cas9 ribonucleoprotein 
We used a co-conversion method (Arribere et al. 2014) for all CRISPR/Cas9 genome 
editing experiments in this study. We injected preassembled Cas9 ribonucleoprotein and 
synthetic single stranded DNA oligos as repair templates (Paix et al. 2015; Figure 1C). Using 
the plasmid pHO4d-Cas9 (Addgene plasmid # 67881), which was a gift from Michael Nonet (Fu 
et al. 2014), the Cas9 protein (eluted in the buffer with 20 mM Hepes pH 7.5, 150 mM KCl, 10% 
Glycerol, 1 mM DTT) was made as previously described (Paix et al. 2015). To anneal tracrRNA 
and crRNAs at a 1:1 ratio, 2.5 µl of 100 µM tracrRNA, 0.5 µl of 100 µM dpy-10 crRNA (for co-
conversion), and 2.0 µl of 100 µM crRNA targeting the gene of interest were mixed in a PCR 
tube, incubated at 94 °C for 2 min in a PCR machine, and cooled to room temperature at the 
bench. The injection solution was prepared as follows: 3.4 µg/µL Cas9 protein, 45.9 µM 
annealed guide RNA mixture, 0.51 µM DNA repair oligo for the gene of interest, and 0.25 µM 
DNA repair oligo for the co-conversion marker dpy-10. The solution was spun at 14549 rcf for 1 
min, put on ice and was used right away. The mixture was injected into the germline syncytium 
of wild-type C. elegans according to a standard microinjection procedure (Mello and Fire 1995). 
We injected 15-20 young adults (P0), cultured each injected P0 on its own NGM Petri plate at 
room temperature, and picked F1 progeny with the co-conversion phenotype after 3-4 days. For 
the experiment to obtain aex-2 revertants, the aex-2(sy1078) animals were used for injection. 
When using unc-58 as the co-conversion marker, we slightly modified the protocol by changing 
the ratio of crRNAs in the annealed guide RNA mixture (1.0 µl of 100 µM unc-58 crRNA, and 1.5 
µl of 100 µM crRNA for the target gene) and the final concentration of the repair template for 
unc-58 (0.51 µM) in the injection solution. A step-by-step protocol is provided in Supplemental 
File S1. 
Screen for successful knock-in events by PCR 
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3-4 days after microinjection, we selected the F1 animals with the dominant co-
conversion phenotype (Roller phenotype for dpy-10), placed them singly onto individual NGM 
Petri plates, and confirmed the presence of the co-conversion phenotype in F2 progeny (Figure 
1C). As CRISPR/Cas9 via injecting preassembled ribonucleoprotein may induce targeted 
somatic mutations in the F1 progeny (Cho et al. 2013), we only genotyped F2 progeny to identify 
F1 animals with heritable genome editing. For each of those F1 animals that produced F2 
progeny with the co-conversion phenotype, about 10 young F2 animals were lysed and 
genotyped (See Supplemental File S1 for a detailed protocol). Two PCR reactions were used: 
one using the common reverse inner primer (oHP013r: 5’-
GCTTATCACTTAGTCACCTCTGCTC-3’) within the repair template and a forward primer 
specific to the target gene to identify F1 animals with successful insertion of the STOP-IN 
cassette; the other one using two outer primers specific to the target gene to determine if the F1 
animals were heterozygotes for the knock-in allele (Figure 1F). The two outer primers specific to 
the target gene were chosen to get a relative small PCR amplicon (< 500 bp) such that a small 
size difference (43-bp insertion of the STOP-IN cassette) could easily be detected on a 2.5% 
agarose gel. The original F1 animals giving F2 progeny with the predicted knock-in bands from 
both PCR reactions were considered positive F1 clones with the desired knock-in alleles. The 
knock-in efficiency (“% of KI” in Table 1) for each genome editing experiment was calculated as 
the number of positive F1 clones divided by the total number of F1 plates genotyped. For positive 
F1 animals that were heterozygotes, several F2 progeny from each plate were singled out to 
identify homozygote F2 animals by genotyping F3 progeny using the same outer primer set. The 
successful insertion of the STOP-IN cassette in homozygous animals was confirmed by Sanger 
sequencing (Laragen, Culver City, CA) of PCR products with the two outer primers. Primer 
sequences used for genotyping are provided in Supplemental Table S2.  
10 
 
For reversion of the aex-2(sy1078) null mutants, we injected young adults of 
aex-2(sy1078) mutants (P0) using the same protocol described above. We screened the F1 
generation for non-constipated F1 animals using a dissecting microscope and transferred each 
candidate onto an individual plate. Several wild-type F2 progeny from each plate were singled 
out to identify homozygotes for revertant aex-2 alleles by the absence of constipated worms in 
the next generation. Likely homozygous aex-2 revertants were genotyped with the same set of 
outer primers used to detect aex-2(sy1078) and the revertant wild-type alleles were confirmed 
by Sanger sequencing. 
Behavioral assays  
The defecation motor program was assayed as previously described (Wang et al. 2013) 
with modifications. Briefly, L4 animals were collected, and then 24 hours later transferred to new 
NGM Petri plates seeded with E. coli OP50, and observed under a dissecting stereomicroscope. 
Each worm was scored for six consecutive defecation cycles. The posterior body wall muscle 
contraction (pBoc) and enteric muscle contraction (EMC) during each defecation cycle were 
recorded using Etho, an event logging Java program 
(http://depts.washington.edu/jtlab/software/otherSoftware.html) (Thomas 1990). “EMC per cycle” 
for each animal was calculated as the ratio of EMC to pBoc. Ten individual animals were 
assayed for each genotype. 
Pumping assays were performed as follows: 24 hours prior to the assay, L4 animals of 
each genotype were moved onto fresh NGM Petri plates with E. coli OP50. The next day, adult 
animals were picked in pairs onto new NGM plates seeded with OP50 and allowed to acclimate 
for 10 minutes. Animals were then recorded on a Wild Makroskop M420 dissecting microscope 
at 80x magnification for 30 seconds. The number of pumping events observed in 30 seconds 
was doubled to obtain the pumping rate (pumps/min).  
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Microscopy 
DIC images of the constipated worms in Figure 2D were taken using a Plan Apochromat 
40x/1.4 Oil DIC objective in a Zeiss Imager Z2 microscope equipped with an Axiocam 506 Mono 
camera using ZEN Blue 2.3 software. 
Statistics 
Where appropriate, Chi-square test or One-way ANOVA with Tukey’s post-test or with 
Dunn's multiple comparisons test were applied (GraphPad Prism) to determine if there were 
significant differences between genotypes, as indicated in results or figure legends. 
Data Availability Statement 
 Strains and plasmids are available upon request. The authors affirm that all data 
necessary for confirming the conclusions of the article are present within the article, figures, 
tables, and supplemental information.  
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Results 
Design of our universal STOP-IN cassette 
 We aimed to develop a cloning-free and streamlined protocol for the design of single 
stranded DNA repair templates to generate putative mutants with well-defined mutations with 
CRISPR/Cas9 and to simplify the detection of knock-in alleles with PCR. To this end, we 
designed a 43-nucleotide-long universal stop knock-in (STOP-IN) cassette that would create 
putative null mutants when inserted within the exons, regardless of the reading frame. The 
cassette contains an exogenous Cas9 target site with a PAM site that has been shown to 
function when inserted into the C. elegans genome (Paix et al. 2017), followed by five stop 
codons, as well as a NheI restriction enzyme site (Figure 1B). Once inserted into the coding 
stand, this STOP-IN cassette will generate stop codons in three reading frames (a tandem pair 
of stop codons for two of the three frames and one stop codon for the third frame; Figure 1B). 
The universal STOP-IN cassette is 43 nucleotides and thus will also create a frameshift in the 
target gene even if stop codon readthrough occurs.  
 Insertion of similar cassettes with stop codons in three reading frames has been used to 
knockout gene activity in zebrafish, C. elegans and mammalian cell lines (Gagnon et al. 2014; 
Farboud and Meyer 2015; Maruyama et al. 2015). The design of our STOP-IN cassette offers 
some unique features. The included exogenous Cas9 target site allows future re-editing of the 
genomic locus, and the NheI site can be used for PCR/RFLP detection. Our cassette also 
allows the use of a single universal inner primer (e.g., we used the universal reverse primer P2: 
5’-GCTTATCACTTAGTCACCTCTGCTC-3’) for detection of successful knock-in events, when 
combined with a gene-specific forward outer primer (P1 in Figure 1F). In addition, the insertion 
of the universal STOP-IN cassette (43 bp) is easy to identify by size shift on agarose gel 
electrophoresis of a PCR product amplified using an outer primer pair flanking the target cut 
site(P1 and P3 in Figure 1F), when the PCR product is less than 500 bp.  
 
13 
 
Generation of putative aex-2 null mutants 
To test if insertion of our universal STOP-IN cassette into the coding sequence could 
generate null mutants, we chose the gene aex-2, which has distinctive and easily observable 
loss-of-function phenotypes. aex-2 encodes a G protein-coupled receptor essential for rhythmic 
enteric muscle contraction (EMC) during the C. elegans defecation motor program. Strong loss-
of-function aex-2(sa3) mutants almost completely lack EMCs, leading to a constipated 
phenotype with a distended intestinal lumen (Mahoney et al. 2008; Figures 2D-2E). We tested 
whether new aex-2 alleles generated using our universal STOP-IN cassette had the same 
phenotype as aex-2(sa3) animals.  
We first selected a guide sequence in the third exon of the aex-2 gene to insert the 
STOP-IN cassette with CRISPR/Cas9 (Figures 2A-2B; see Supplemental File S1 for a detailed 
protocol). Following microinjection and identification of F1 animals showing the co-conversion 
marker (Figure 1C), 7 of the 16 F1 lines genotyped (44%) had successful insertion of the STOP-
IN cassette (Figure S1; Table 1). Two different STOP-IN alleles of aex-2 were retained (sy1078 
and sy1079), originating from different F1 animals, and confirmed by Sanger sequencing (data 
not shown). Both sy1078 and sy1079 animals, behaved similarly to aex-2(sa3) mutants and 
were completely defective in EMC during the defecation cycle and had distended intestinal 
lumens (Figure 2D and 2E), consistent with the idea that both sy1078 and sy1079 were null 
alleles. Thus, our STOP-IN method can generate putative null alleles of target genes. 
 
Reversion of aex-2 mutants to the wild type with a second CRISPR/Cas9 
Next, we tested if we could revert the STOP-IN alleles of aex-2 back to wild type using 
the exogenous Cas9 target site that was included the STOP-IN cassette. We targeted the 
aex-2(sy1078) mutants using a crRNA for the exogenous Cas9 target site, and a 71-nuceotide-
long single stranded DNA repair oligo with wild-type aex-2 sequence (Figure 2C). We obtained 
F1 animals that, unlike the parental aex-2(sy1078), were not constipated, indicating that they 
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contained revertant alleles and possessed a normal defecation cycle. We retained two revertant 
aex-2 alleles (sy1078sy1090 and sy1078sy1091) and confirmed the wild-type sequence of the 
aex-2 locus around the Cas9 target site with Sanger sequencing. Both aex-2 revertants showed 
wild-type levels of EMC and had normal intestinal lumens (Figures 2E-2F). Thus, the null alleles 
with the STOP-IN cassette can be reverted back to wild-type. Reversion of a null mutant to wild 
type offers a convenient and convincing way to prove that the phenotype associated with a null 
mutation is caused by loss of the gene’s function.  
 
Calponin-like protein knockouts have pharyngeal pumping defects 
 We used our STOP-IN method to generate null alleles for the poorly understood and 
uncharacterized clik genes. These genes have been shown to be highly expressed and almost 
completely specific for pharyngeal muscle: clik-1, clik-2, and clik-3 (Yuet et al. 2015). These 
genes encode proteins that share some homology with human Calponin-1, a protein found in 
smooth muscle cells. Two unique types of protein domains are found in human Calponin-1: a 
single calponin homology (CH) domain, and multiple calponin family repeats (CFRs). CLIK-1, 
CLIK-2, and CLIK-3 in C. elegans all contain varying numbers of CFRs but no CH domains 
(Figure 3A). CFRs are thought to be actin-interacting domains, negatively affecting actin-cofilin 
interactions (Yamashiro et al. 2007). Given the highly specific expression of the clik genes in the 
pharynx, we generated putative null mutants of these genes and assayed for pumping defects. 
We inserted the STOP-IN cassette in early exons for clik-1 and clik-2, both of which 
have single isoforms (Figure 3A). clik-3 has four isoforms, of which the c isoform is the shortest 
and consists of the last exon. Thus, we created alleles of clik-3 in which the STOP-IN cassette 
was inserted at two different locations: one in the second exon (sy1086 and sy1087, affecting 
isoforms a, b, and d) and the other in the last exon (sy1082 and sy1083, affecting all isoforms, 
Figure 3A). 
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We used these alleles to determine if any of these three genes are involved in the 
regulation of pharyngeal pumping. clik-1 null mutants (sy1084 and sy1085) were similar to the 
wild type, suggesting that clik-1 is not essential for pharyngeal pumping (Figure 3B). For clik-3, 
we found that only the sy1082 and sy1083 alleles affecting all isoforms displayed a mild (14% 
decrease) pumping defect. The sy1086 and sy1087 alleles affecting isoforms a, b, and d, did 
not exhibit pumping defects (Figure 3B). 
We were unable to homozygose the clik-2 null alleles with the STOP-IN cassette, 
sy1122 and sy1123, leading us to believe clik-2 null mutants were lethal. We thus created 
balanced sy1122/tmC30[tmIs1243] and sy1123/tmC30[tmIs1243] strains using a multiple-
inversion balancer (Dejima et al., 2018). These animals appeared wild-type for growth and 
pumping. However, their progeny included tiny, starved L1-arrested animals which did not 
appear to pump, in roughly Mendelian ratios (Figures 3C-3D). Close observation of these 
arrested animals showed barely perceptible fasciculation of pharyngeal muscles and the grinder, 
but no full contractions. When constructing our clik-2 null mutants, we also obtained two in-
frame insertion alleles for clik-2, sy1116 (57-bp insertion) and sy1117 (6-bp insertion), which 
were likely the result of error-prone NHEJ. Pharyngeal pumping rate was decreased by about 
15% in sy1116 animals; sy1117 animals appeared normal (Figure 3B).  
 
Robustness of the knock-in method  
To test the robustness of our STOP-IN method to generate putative null mutants, we 
used it to generate putative null mutants for 17 additional genes, most of which did not have null 
mutants available. We found that, on average, 46% of F1 animals with a co-conversion 
phenotype (Rol for dpy-10 or Unc for unc-58, n = 694) had successful insertion of the STOP-IN 
cassette (ranging from 11% to 100%; Table 1). We noticed that we could not homozygose some 
of the alleles obtained, and we speculated that these mutants were likely to be lethal (Table 1). 
The knock-in efficiency was markedly lower for those putative lethal genes than for non-lethal 
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genes (27 % vs 59%; n = 267 and 427, respectively; P < 0.0001, Chi-square test). However, the 
knock-in efficiency for the lethal genes may be underestimated, as we could not recover the F1 
animals for these genes that contained two loss-of-function alleles induced by CRISPR/Cas9. 
While most of the candidate F1 animals with desired knock-in events were heterozygotes, 
we noticed that for some genes, a small fraction of F1 animals appeared to be homozygous for 
the knock-in null alleles, as they had a correct PCR product with the outer and the internal 
primer pair, but only had the bigger PCR band for the knock-in allele with the outer primer pair 
(Examples shown in Figures S1 and S2). However, it was also possible that these putative F1 
homozygotes could be heterozygotes (e.g., one successful knock-in allele and the other allele 
with a deletion that removed a region where one of both external primers bind). Indeed, 
CRISPR/Cas9 has been shown to create two independent heritable alleles in a single F1 animal 
(Cho et al. 2013). As we generally had more than two F1 animals that are heterozygotes and to 
make sure the homozygotes were from single alleles, we always singled out several F2 progeny 
from each of independent heterozygote F1 animals and identified the homozygotes for null 
knock-in alleles by genotyping the F3 progeny.  
We also found that partial repair occurred in a small fraction of animals that we screened, 
in which the knock-in PCR band with the outer primer pair appeared to be slightly smaller than 
the predicted size (Figures S1 and S2). Such partial repair has been reported before (Arribere et 
al. 2014). Thus, we recommended validating homozygote knock-ins by sequencing the PCR 
products with the outer primer pair in F3 homozygotes. 
 
17 
 
Discussion 
We report a simple and robust CRISPR/Cas9 method to generate putative C. elegans 
null mutants by inserting a 43-neucleotide-long knock-in cassette (STOP-IN) in the exons of 
target genes. We report high knock-in efficiency (46%, n = 694) in F1 co-converted animals that 
we screened. We applied our STOP-IN method to generate null mutants for 21 genes, including 
three clik genes which are specifically expressed in the pharyngeal muscles (Yuet et al. 2015).  
We showed that clik-2 was essential for pumping in C. elegans. As a proof of concept, we also 
showed that null alleles generated by our STOP-IN method can be reverted to wild type by a 
second genome editing event at the exogenous Cas9 target site included in the STOP-IN 
cassette. 
 
Useful features of our STOP-IN method to generate null mutants 
The main features of our STOP-IN method are as follows. First, it is straightforward to 
design the guide sequence and the repair template, without the need to consider the reading 
frame of the target gene at the engineered locus or to introduce other mutations to create a 
restriction enzyme or primer binding site for detection of successful insertion. Second, similar to 
previously described CRISPR/Cas9 protocols that used preassembled Cas9 ribonucleoprotein 
(Cho et al. 2013; Paix et al. 2015), our method is cloning-free, as all the reagents for the 
genome editing, including Cas9 protein, tracrRNA, crRNAs, and single stranded DNA repair 
oligos, are commercially available. Third, our method is highly efficient. Specifically, 46% of F1 
animals with a co-conversion phenotype that we genotyped had the desired knock-in events. 
Fourth, combined with an outer primer specific to the gene of interest, the common inner primer 
designed in the universal STOP-IN cassette makes it easy to detect successful knock-in events 
by PCR. Fifth, the null alleles generated with our method can be reverted to the wild type allele 
with a second genome editing at the exogenous Cas9 target sequence included in the STOP-IN 
cassette. This can be used to prove that the null mutation in the gene of interest is causative for 
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the phenotype observed. In principle, the exogenous Cas9 target site can be also used for other 
types of genome editing; for example, inserting an in-frame gfp reporter fused to the gene of 
interest.  
 
Potential modifications of our STOP-IN method 
The modular design of the STOP-IN cassette offers opportunities for future modification. 
While we selected the exogenous Cas9 target site with a PAM site (5’-
GGGAAGTTTGTCCAGAGCAGAGG-3’) and the restriction enzyme NheI (5’-gctagc-3’) in our 
current design, it can be modified to generate null alleles, as long as the core sequence with 
stop codons in all three reading frames and frameshifts is preserved. For example, the 
exogenous Cas9 target site can be replaced if an improved sequence is reported for C. elegans. 
Similarly, the restriction enzyme site can be changed to others, as desired.  
In this study, we successfully used dpy-10 or unc-58 as co-conversion markers to 
enhance detection of successful knock-in events in target genes with our STOP-IN method. 
Other reported co-conversion markers, such as pha-1, unc-22, sqt-1, and rol-6 (Ward 2014; Kim 
et al. 2014; Arribere et al. 2014), should work as well. In principle, our STOP-IN method should 
also work with other CRISPR/Cas9 delivery strategies, including injecting mRNA or plasmids 
that express Cas9 and guide RNAs (reviewed by Dickinson and Goldstein 2016), instead of 
preassembled Cas9 ribonucleoprotein used in this study. While these alternative strategies may 
make our STOP-IN method more useful in other experimental systems, we expect that the 
knock-in efficiency with injection of mRNA or plasmids may be lower than delivery of 
preassembled Cas9 ribonucleoprotein (Farboud et al. 2018). 
Unlike deletions obtained from CRISPR/Cas9 protocols not involving HDR, which 
generally have unpredictable endpoints and may affect gene activity in unknown ways, null 
alleles generated using our STOP-IN method are well defined and reproducible; the alleles of 
the target gene generated using the same guide RNA and the repair template will have exactly 
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the same genetic mutation. This consistency will increase robustness in comparing interactions 
between genes. With its high efficiency, our STOP-IN method can be used to generate 
molecularly indistinguishable null alleles of the target gene in multiple genetic backgrounds: 
wild-type background, existing mutants, or in other isolates of the same species. In this way, 
one can compare single, double, and even multiple mutants to infer genetic interactions and 
examine complex effects of the target gene in different genetic backgrounds. Our method is 
particularly useful when close linkage impedes creation of double-mutant animals by traditional 
recombination. In addition, as the relatively small universal STOP-IN cassette is likely to have 
minimal effects on gene structure, guide sequences in isoform-specific exons may be used to 
generate isoform-specific null mutations, as we did for clik-3 (Figure 3A). With its easy design 
and high knock-in efficiency, we envision that our universal STOP-IN cassette will facilitate the 
generation of new null mutants in C. elegans and potentially other genetic model organisms, 
which can be used to understand gene function. 
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Figures and Figure Legends 
 
 
Figure 1 The CRISPR/Cas9 pipeline to generate null mutants by inserting a universal stop 
knock-in (STOP-IN) cassette. (A) Diagram showing the recognition of the target DNA by Cas9 
ribonucleoprotein from Streptococcus pyogenes. The ribonucleoprotein complex of Cas9 with 
crRNA and tracrRNA recognizes the target DNA with the first 20 nucleotides (nt) of crRNA 
homology (the guide sequence) preceding a PAM site (‘5-NGG-3’) and generates a double-
strand break three nucleotides 5’ of the PAM site. (B) Design of the 43-nucleotide-long universal 
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stop knock-in (STOP-IN) cassette (represented by the red rectangle) used in this study, which 
includes an exogenous Cas9 target site (the PAM site is underlined), stop codons and 
frameshifts in all three reading frames, and the recognition site for the restriction enzyme NheI. 
RF, reading frame, as indicated by grey boxes. Cyan and purple boxes represent the stop 
codon TAA and TGA, respectively. Reading frames 1 and 2 have two stop codons; reading 
frame 3 has one stop codon. (C) The recipe of the ribonucleoprotein injection mixture and the 
workflow of the CRISPR/Cas9 protocol to generate null mutants. With the co-conversion method, 
two crRNAs and two DNA repair oligos (one pair for the co-conversion marker, dpy-10 or unc-58, 
and the other pair for the target gene) are included in the same injection mixture; the mixture is 
directly injected into the gonads of adult hermaphrodites. Animals with genomes affected by 
CRISPR/Cas9 and template-directed repair are identified by the co-conversion marker 
phenotype; in the figure, these are roller animals with dpy-10 conversion. (D and E) Design of 
the DNA repair oligo for the target gene. The oligo contains two ~35-nucleotide-long homology 
arms identical to the sequences flanking the Cas9 cut site and on the same strand as the PAM 
site (5’-NGG-3’). If the PAM site is on the coding strand (1D), the STOP-IN cassette sequence 
as shown in (1B) is included in between the two homology arms to comprise the DNA repair 
oligo. If the PAM site is on the non-coding strand (1E), the reverse complement of the STOP-IN 
cassette sequence as shown in (1B) is added between the two homology arms to make the 
DNA repair oligo. (F) Diagram showing the placement of primers for PCR reactions to detect 
successful knock-in events. P1 and P3 are outer primers that are specific to the target gene, 
while P2 is a common internal primer within the universal STOP-IN cassette. These primers can 
be used to detect the successful insertion of the STOP-IN cassette via PCR, as shown in the 
cartoon agarose gels below.  
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Figure 2 Genome engineering of the aex-2 gene. (A) The gene structure of aex-2. The black 
arrowhead indicates the position of the Cas9 target site in the third exon of aex-2, which we 
used to insert the universal STOP-IN cassette to generate the two new aex-2 null alleles, 
sy1078 and sy1079. The asterisk denotes the mutation sa3, a strong loss-of-function allele of 
aex-2. Black boxes are exons and white box is the 3’ UTR. The lines connecting the black 
boxes are introns. Scale bar, 500 bp. (B) Scheme showing the generation of putative aex-2 null 
alleles, sy1078 and sy1079, using CRISPR/Cas9 and a DNA repair oligo with the universal 
STOP-IN cassette. (C) Diagram showing the reversion of aex-2(sy1078) to wild-type sequence, 
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using the exogenous Cas9 target site included in the STOP-IN cassette and a wild-type DNA 
oligo with two ~35-nucleotide-long homology arms. (D) Differential interference contrast (DIC) 
images showing the constipation phenotypes of young adults with indicated genotypes. Yellow 
lines outline the posterior intestinal lumens. Compared to wild-type and aex-2(sy1078sy1091) 
animals, aex-2(sa3) and aex-2(sy1078) mutants both have distended intestinal lumens. Scale 
bar, 50 µm.  (E) Quantification of enteric muscle contraction (EMC) during the defecation motor 
program in adult animals with indicated genotypes. Each dot represents the percentage of EMC 
observed per defecation cycle from an individual animal. n = 10 animals for all genotypes. 
Horizontal bars indicate the mean; vertical bars are SEM. ***, P < 0.001 and **, P < 0.01, 
compared to wild type; ###, P < 0.001 and ##, P < 0.01, compared to aex-2(sy1078); One-way 
ANOVA with Dunn's multiple comparisons test. 
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Figure 3 Mutants of clik genes and pharyngeal pumping. (A) Gene structures of three 
C. elegans genes encoding Calponin-like proteins: clik-1, clik-2, and clik-3. Green blocks 
represent the calponin family repeats (CFRs). Magenta arrowheads indicate Cas9 cut sites 
where the STOP-IN cassette inserted in indicated alleles, except for sy1116 and sy1117, which 
are small insertions likely resulting from NHEJ during repair. nt, nucleotide. Scale bars, 500 bp. 
(B) Quantification of pumping rate of clik-1, clik-2, clik-3 mutants. Each green dot represents the 
mean pumping rate of one adult animal over 30 seconds on food. The clik-2(sy1116) partial 
loss-of-function mutants, clik-3(sy1082), and clik-3(sy1083) null mutants have reduced pumping 
rates, compare to the wild type. Horizontal bars are the mean, vertical bars are SEM. n = 10 for 
all genotypes. * P < 0.05, One-way ANOVA with Tukey’s post-test. (C) Table showing that clik-
2(sy1122) and clik-2(sy1123) null mutants are recessive lethal. L1, the first larval stage of C. 
elegans. The balancer allele used in (C and D) is tmC30[tmIs1243], an aneuploidy-free and 
structurally defined balancer for the part of chromosome X where clik-2 is located. (D) Bright-
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field images showing a clik-2(sy1122)/balancer heterozygote (left) and a clik-2(sy1122) 
homozygote (right), roughly 16-19 hours after hatching. Scale bars are 20 µm. 
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Table 1. Summary of our CRISPR/Cas9 knock-in results.  
  
Target gene Allele Guide sequence 
# of F1 
plates 
genotyped 
# of 
KI 
% of KI Lethal 
Co-conversion 
marker 
clik-1 sy1084 and sy1085 CTCTGGCTCTTGGTTCTCGT 46 24 52% 
 
dpy-10 
clik-2 sy1122 and sy1123 GTATCCTTGCTTCTTGTCCT 105 28 27% Yes dpy-10 
clik-3 sy1082 and sy1083 GTCACGTGGTGTTCCGAAAC 46 6 13% 
 
dpy-10 
clik-3 sy1086 and sy1087 ATTGCTTGGCACCTCGACGG 38 13 34% 
 
dpy-10 
T05C3.2 sy1080 and sy1081 AGAACGAAACGCGCTAATGG 45 16 36% 
 
dpy-10 
cul-3 sy1153 and s1154 ACTTTTGAAGCGTGCCATAC 40 12 30% Yes dpy-10 
dlg-1 sy1155 and sy1156 ACACTCCTACAACAGTCGTC 46 17 37% Yes dpy-10 
ubq-1 sy1157 and sy1158 AAAAACTATCACCCTGGAGG 19 2 11% Yes dpy-10 
hpo-29 sy1159 and sy1160 ATCTCCGTTCATATGTCTGC 12 2 17% Yes dpy-10 
Y106G6H.8 sy1076 and sy1077 AGGCCAGCCAGACGAATAAT 24 21 88% 
 
dpy-10 
aex-2 sy1078 and sy1079 ATTACTGCAGCGACATGGGG 16 7 44% 
 
dpy-10 
Y71H2AM.20 sy1176 and sy1177 TCTCCTAGCCAGCGTTCTTC 22 4 18% Yes dpy-10 
set-16 sy1178 and sy1179 CTGACGTTGTTGCTGCATGG 23 7 30% Yes dpy-10 
C01B10.10 sy1114 and sy1115 GCTCTGGGTCCATGTTGAAT 24 20 83% 
 
dpy-10 
C56G2.15 sy1120 and sy1121 ACGACATTGGAGGGGACTGA 23 21 91% 
 
dpy-10 
C01B10.4 sy1131 and sy1132 CATTTGGAAGGTGCAGAGAT 23 23 100% 
 
dpy-10 
C23H4.2 sy1163 and sy1164 GCTTTGCAAACGGAACACTC 23 18 78% 
 
dpy-10 
C04G6.4 sy1165 and sy1166 ATATTTGGCTGGAGAACTGG 24 15 63% 
 
unc-58 
ttc-36 sy1167 and sy1168 CGAGAGAGAAGGTGTCGCGT 24 14 58% 
 
unc-58 
ZC376.2 sy1170 and sy1171 GGAGGCGAAGGAGTATAAAG 24 19 79% 
 
dpy-10 
cpn-4 sy1172 and sy1173 TGTTGAAGCTGGATACTTGT 24 13 54% 
 
dpy-10 
Y55F3BL.4 sy1174 and sy1175 CTGGTCACTGGTAGAAAAGC 23 20 87% 
 
unc-58 
 
Footnote: KI, knock-in events. % of KI = # of KI / # of independent plates genotyped. 
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Supplemental Figures 
 
 
Figure S1 Genotyping result to identify null aex-2 alleles with the universal STOP-IN 
cassette. (A) Diagram of the primers used for genotyping aex-2. The outer primer pair 
(oHP029f and oHP030r) will yield a 246 bp PCR product from the knock-in allele and a 203 bp 
PCR product from the wild-type allele; the outer and inner primer pair (oHP029f and oHP013r) 
will produce a 204 bp PCR product from the knock-in allele and no PCR product from the wild-
type allele. The red rectangle represents the universal STOP-IN cassette described in the 
manuscript. (B) Electrophoresis of PCR products from the genotyping experiments with 
indicated primers of F2 progeny from 16 different F1 animals (Samples 1 to 16) that had the co-
conversion phenotype, Rol. Samples 17 and 18 were controls: the wild-type strain used for 
injection and the bacterial food for C. elegans, respectively. The black arrow on the left indicates 
the correct PCR band (246 bp) from the desired knock-in alleles from the PCR reaction using 
oHP029f and oHP030r. The red arrowhead on the right indicates the correct band (204 bp) for 
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the desired knock-in alleles from the PCR reaction using oHP029f and oHP013r. The samples 
with numbers in red (2, 3, 6, 9, 10, 13, and 15) were heterozygous for the knock-in alleles. 
Samples 1 and 16 were heterozygous for small deletions. Sample 11 appeared to be 
homozygous for a small insertion. The PCR reactions appeared to fail in samples 4 and 5. M1 
and M2 represent 50 bp and 100 bp DNA ladders, respectively (NEB, Ipswich, MA).  
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Figure S2 Genotyping result to identify null C01B10.10 alleles with the universal STOP-IN 
cassette. (A) Diagram of the primers used for genotyping C01B10.10. The outer primer pair 
(oHP039f and oHP040r) would yield a 214 bp PCR product from the knock-in allele and a PCR 
171bp product from the wild-type allele; the outer and inner primer pair (oHP039f and oHP013r) 
would only produce a PCR product of 190 bp band for the knock-in allele and no product from 
the wild-type allele. The red rectangle represents the STOP-IN cassette described in the 
manuscript. (B) Electrophoresis of PCR products with indicated primers from genotyping F2 
progeny of 24 different F1 animals that had the co-conversion phenotype, Rol. The black arrow 
on the left indicates the correct band (214 bp) for successful knock-in alleles from a PCR 
reaction using oHP039f and oHP040r. The red arrowhead on the right indicates the correct 
band (190 bp) for successful knock-in allele from a PCR reaction with oHP39f and oHP13r. The 
16 samples in red (3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 16, 18, 19 and 24) were heterozygous 
for the desired knock-in alleles. Four samples (1, 15, 20, and 22) were putative homozygous for 
the desired knock-in allele. Sample 2 was likely to be homozygous for a small insertion. The 
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three samples left (17, 21, and 23) were likely to be wild-type alleles. M1 and M2 represent 50 
bp and 100 bp DNA ladders, respectively (NEB, Ipswich, MA).   
